Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
And these are often to treat specific forms of cancer or rare childhood diseases with super narrow populations and huge price tags. And to put numbers around that, we're talking like total market size of a couple hundred thousand people or fewer, as few as like 30%. 300 people in these super rare orphan diseases.
0
💬
0
Comments
Log in to comment.
There are no comments yet.